eISSN: 2391-6052
ISSN: 2353-3854
Alergologia Polska - Polish Journal of Allergology
Bieżący numer Archiwum Artykuły zaakceptowane O czasopiśmie Suplementy Zeszyty specjalne Rada naukowa Bazy indeksacyjne Prenumerata Kontakt Zasady publikacji prac Opłaty publikacyjne Standardy etyczne i procedury
Panel Redakcyjny
Zgłaszanie i recenzowanie prac online
Wyszukiwanie
Zasady redakcyjne
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Otwarty dostęp

without publication fees
Poleć ten artykuł:
Wyślij znajomemu
Udostępnij:
Opis przypadku

Unexpected cause of headache in a patient with Noonan syndrome: aseptic meningitis

Hacer Efnan Melek Arsoy
1
,
Öner Özdemir
2
,
Ümmügülsüm Dikici
2
,
Ece Tüsüz Önata
2
,
Recep Polat
3

  1. Department of Pediatrics, Faculty of Medicine, Sakarya University, Sakarya Training and Research Hospital, Sakarya, Türkiye
  2. Department of Pediatric Immunology and Allergic Diseases, Faculty of Medicine, Sakarya University, Sakarya Training and Research Hospital, Sakarya, Türkiye
  3. Division of Pediatric Endocrinology, Faculty of Medicine, Sakarya University, Sakarya Training and Research Hospital, Sakarya, Türkiye
Alergologia Polska – Polish Journal of Allergology 2024; 11
DOI: https://doi.org/10.5114/pja.2024.142944
Data publikacji online: 2024/09/13
Plik artykułu:
- Unexpected cause.pdf  [0.21 MB]
Pobierz cytowanie
 
Metryki PlumX:
 
1. Wallgren A. Une nouvelle maladie infectiouse du système nervoux central? Acta Paediatr 1924; 4: 158-82.
2. Kretowska-Grunwald A, Krawczuk-Rybak M, Sawicka-Zukowska M. Intravenous Immunoglobulin-induced aseptic meningitis – a narrative review of the diagnostic process, pathogenesis, preventative measures and treatment. J Clin Med 2022; 11: 3571.
3. Bharath V, Eckert K, Kang M, et al. Incidence and natural history of intravenous immunoglobulin-induced aseptic meningitis: a retrospective review at a single tertiary care center. Transfusion (Paris) 2015; 55: 2597-605.
4. Asano T, Koizumi S, Mishina-Ikegami K, et al. Increased levels of monocyte chemoattractant protein-1 in cerebrospinal fluid with gamma globulin induced meningitis. Acta Paediatr 2010; 99: 164-5.
5. Sharland M, Burch M, McKenna WM, et al. A clinical study of Noonan syndrome. Arch Dis Child 1992; 67: 178-83.
6. Tartaglia M, Cordeddu V, Chang H, et al. Paternal germline origin and sex-ratio distortion in transmission of PTPN11 mutations in Noonan syndrome. Am J Hum Genet 2004; 75: 492-7.
7. Aoki Y, Niihori T, Inoue S, et al. Recent advances in RASopathies. J Hum Genet 2016; 61: 33-9.
8. Management of Noonan Syndrome – A Clinical Guideline -Noonan Syndrome Guideline Development Group. Available from: https://rasopathiesnet.org/wp-content/uploads/2014/01/265_Noonan_Guidelines.pdf
9. Ng KF, Goenka A, Manyika F, et al. The multifaceted syndromic primary immunodeficiencies in children. J Clin Med 2023; 12: 4964.
10. Walter JE, Ayala IA, Milojevic D. Autoimmunity as a continuum in primary immunodeficiency. Curr Opin Pediatr 2019; 31: 851-62.
11. Sekul EA, Cupler EJ, Dalakas MC. Aseptic meningitis associated with high-dose intravenous immunoglobulin therapy: frequency and risk factors. Ann Intern Med 1994; 121: 259-62.
12. Orbach H, Katz U, Sherer Y, et al. Intravenous immunoglobulin. Clin Rev Allergy Immunol 2005; 29: 173-84.
13. Cherin P, Marie I, Michallet M, et al. Management of adverse events in the treatment of patients with immunoglobulin therapy: a review of evidence. Autoimmun Rev 2016; 15: 71-81.
14. Şeker E, Özdemir Ö, Pala A. Intravenous immunoglobulin therapy in COVID-19 disease. Sak Med J 2021; 11: 470-2.
15. Jolles S, Sewell WAC, Leighton C. Drug-induced aseptic meningitis. Drug Saf 2000; 22: 215-26.
16. De Felice ELT, Toti GF, Gatti B, et al. Acute aseptic meningitis temporally associated with intravenous polyclonal immunoglobulin therapy: a systematic review. Clin Rev Allergy Immunol 2024; 66: 241-9.
17. Wada A, Yoshida R, Oda K, et al. Acute encephalopathy associated with intravenous immunoglobulin therapy. Am J Neuroradiol 2005; 26: 2311-5.
18. Carcavilla A, Suárez-Ortega L, Sánchez AR, et al. Noonan syndrome: genetic and clinical update and treatment options. An Pediatría Engl Ed 2020; 93: 61.e1-14.
Copyright: © Polish Society of Allergology This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-No Derivatives 4.0 International (CC BY-NC-SA 4.0). License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.



Termedia
O Wydawnictwie Oferty Newsletter Kontakt Praca
Polityka prywatności Polityka reklamowa Napisz do nas Nota prawna Regulamin
Na skróty
Czasopisma Aktualności Książki eBooki Konferencje i webinary
Serwisy
KONGRES TOP MEDICAL TRENDS Koronawirus Zalecenia i rekomendacje Lekarz POZ Kurier Medyczny Dermatologia Diabetologia e-Praktyka Leczenia Ran Ginekologia Neurologia Onkologia Pulmonologia Reumatologia Menedżer Zdrowia Warto wiedzieć
e-Akademia
e-Akademia Raka Płuca e-Akademia MAFLD e-Akademia Zaburzeń Mikrobioty e-Akademia POChP e-Akademia Chorób Naczyń e-Akademia Chorób Cywilizacyjnych Akademia Zapalenia typu 2 Akademia AZScience
© 2024 Termedia Sp. z o.o.
Developed by Bentus.